Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Neuroendocrinol. 2014 Feb;26(2):80–88. doi: 10.1111/jne.12129

Figure 3.

Figure 3

Mean ± SEM 5HT1A BPND in the (mPFC (medial prefrontal cortex) during the placebo (closed bar) and the oestradiol (E2; open bar) for each group of females. The asterisk shows that s-variant 5HTTLPR females show decreased levels of 5HT1A BPND in the mPFC compared to l/l variant females, regardless of treatment condition.